Valeant Changes Strategy, Overhauls Board

Valeant Pharmaceuticals announced it has nominated three new independent directors to its board as it also plans to replace five board members. Bloomberg's Drew Armstrong reports on efforts by company to reset operations. He speaks on "Bloomberg ‹GO›." (Source: Bloomberg)

Full Show: Bloomberg Businessweek (09/22)
27:55 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Julia Chatterley talk with the writers who break news on a weekly basis and get a lighter touch from the editor who oversees the Etc. section. (Source: Bloomberg)
  • Who Moved the Most on Bloomberg's Billionaire Index 9/22
  • Full Show: Bloomberg Best (09/22)
  • Panama Min. Says Anonymous Corporations Are in the Past